Supplementary protection certificate waiver: no deal legislation
Detail of outcome
The government’s response to this consultation is now available.
This response sets out the government’s intended changes to the supplementary protection certificate (SPC) waiver legislation.
These changes will ensure that the legislation continues to work as UK law after the end of the transition period.
Original consultation
Consultation description
The EU has recently made changes to legislation on supplementary protection certificates (SPCs), to introduce an “SPC manufacturing waiver”. The waiver allows third party manufacturers to make SPC-protected medicines in certain circumstances.
If the UK leaves the EU without a deal, these changes will automatically become UK law on exit day. Parts of the retained changes will need fixing so that they continue to work as UK law.
The government is seeking views on how we propose to make those fixes. The document explains what the fixes are, and what the proposed legislation looks like.
Documents
Updates to this page
Last updated 13 July 2020 + show all updates
-
Removal of 'Analysing feedback' note and replacement. Added 'Outcome for consultation' with link.
-
First published.